A graft-versus-host reaction was induced in (BALB/c X C5 7BL/6)F1 mice by intravenous injection of BALB/c spleen cells. Six days later, the mice received subcutaneous grafts of a chemically induced BALB/c sarcoma. The growth of the tumor grafts was accelerated.
One of the immunological methods that have been used in cancer therapy is the attempt to transfer immunity with lymphocytes frotn deliberately immunized donors or from donors suspected of being resistant to cancer of the same antigenic type (1-3). As the infusion of large numbers of foreign lymphocytes into cancer patients (whose cellular immune mechanisms are frequently impaired) carries the risk of a graft-versus-host reaction, it is of interest to enquire whether and how a graft-versus-host reaction affects the growth of tumors. It has been reported that graft-versus-host reactions in mice produce prolonged survival of H-2 histoincompatible skin grafts (4, 5). Thus, alldgeneic cells might exert a similar but undesirable efect on neoplastic cells, comparable to what was observed wvith skin allografts in mice. On the other hand, in the case of a transl)lanted leukemia in guinea pigs, an inhibitory effect on tumor growth has been observed (6, 7) . We report here the opposite: accelerated growth of a transplanted sarcoma in mice.
The tumor, BALB/c 9 sarcoma Meth A, was induced by subcutaneous injection of 3-methylcholanthrene. It was maintained as ascites tumor in serial passage in BALB/c mice. Sarcoma Meth A was shown previously to be strongly immunogenic in syngeneic mice. IIi the experiments reported here, 1.25 X 105 tumor cells were inoculated into the abdominal skin of 12-week-old (BALB/c X C57BL/6)Fl mice. A graft-vershs-host reaction was induced in these mice by intravenous injection of BALB/c spleen cells.
In the experiment shown in Fig. 1 planted leukemia cells. As we try to explain our results, we can only speculate whether the stimulation of tumor growth by the graft-versus-host reaction was due (a) to suppression of the cellular immune response to tumor antigens or (b) to augmented production of "enhaicing" antibody. As antibody to surface antigens of tumor cells has been shown generally to inhibit leukemias on the one side (12) and enhance the growth of solid tumors on the other (13) rule, difficult to demonstrate in vitro inl the serum from even highly immunized mice (14) . Whether transferred serum from tumor-bearing mice that undergo a graft-versus-host reaction will enhance the growth of Meth A in vivo, remains to be seen, Other possibilities that might explain our results must be also kep't in mind, such as the destruction by the graft-versus-host reaction of "T killer cells" or a p)otentiation of regulatory mechanisms similar to those produced during antibody production (15) (16) (17) . Whatever the mechanism, it has to be recognized that, iin certain circumstances, the graft-versushost reaction induced by the transfer of allogeneic lymphoid cells may accelerate rather than retard tumor -growth, a point that must be remembered when human cancer therapy is considered.
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